Hospital Chains Say Elective Surgery Slump Has Bottomed Out, But Not Reversed

Elective surgery volumes weakened across the major for-profit hospital operators in the first half of 2026, and executives speaking this week at the Wells Fargo Healthcare Conference made clear they aren't counting on that trend to reverse. Instead, they're planning around it.

The pullback has a fairly consistent explanation across the sector. Executives pointed to three overlapping forces: disenrollment from Affordable Care Act exchange plans, growing price sensitivity among patients who still have coverage, and early friction from the federal phase-out of Medicare's inpatient-only list. None of the four companies framed this as a company-specific problem. All described it as a market-wide demand shock.

HCA's numbers illustrate the scale. Same-facility inpatient surgeries fell 2.3% year over year in the second quarter, while outpatient surgeries dropped 3.4%. CEO Sam Hazen offered a modest note of optimism, suggesting deductible dynamics could shift behavior later in the year. "It's possible that the consumer sentiment thing could ease a little bit as people get to their deductibles and find that in the fourth quarter they actually now is a good time to do it," he said. He was careful to hedge that view: "We'll have to see."

Universal Health Services posted a smaller decline, with overall surgical volumes down 0.8% in the second quarter. CFO Steve Filton noted that figure was actually "an improvement over the prior period," a small silver lining in an otherwise soft comparison. UHS also reported no meaningful split between elective and non-elective procedure trends, unlike Community Health Systems, which flagged a multi-quarter dip specifically among commercially insured elective patients.

CHS CFO Jason Johnson reaffirmed that characterization on Wednesday, attributing the softness to consumer confidence rather than any shift in the company's own payment policies for procedures, a distinction he stressed given recent scrutiny over hospitals asking patients to pay upfront.

Tenet Healthcare's results tell a similar story with a bit less severity. Hospital surgeries declined 0.7% year over year in the second quarter and 0.8% across the first half. Even its ambulatory arm, United Surgical Partners International, wasn't immune: same-facility surgical cases at USPI fell 1.2% in the quarter and 0.6% over six months. CEO Saum Sutaria said the weakness concentrated in hospitals located in states hit hardest by exchange disenrollment, while outpatient elective procedures, both at Tenet hospitals and at USPI's ambulatory centers, "were actually quite strong."

Guidance Bakes In the Slowdown, Not a Recovery

The more telling signal from this week's conference wasn't the historical numbers. It was how executives are modeling the future.

UHS has already folded the softer volumes into its full-year outlook, trimming 50 basis points off overall volume growth projections for its acute care business. Filton was explicit that this wasn't a temporary adjustment but a baked-in assumption. HCA took a similar approach: its updated guidance assumes surgical volumes and overall demand "remain about the same" for the rest of the year, with no rebound built in.

That's a meaningful signal for anyone tracking hospital labor and staffing plans. Surgical volume is a direct input into operating room staffing, nursing schedules, and capital equipment utilization. When management teams tell investors they're not modeling a recovery, it implies staffing levels and hiring plans are also being calibrated to a flatter demand curve rather than a seasonal dip. That has knock-on effects for surgical techs, OR nurses, and anesthesia staffing agencies that price their services around expected case volume.

Executives were careful to separate near-term volume softness from their longer-term view of demand. Sutaria said Tenet is now watching revenue more closely than raw surgical volume counts, framing the company's investment focus around high-acuity surgical capabilities that free up inpatient capacity elsewhere in the system. Filton echoed a similar acuity story at UHS, noting inpatient volumes in more complex procedures actually rose, which he tied to investments in robotics and equipment upgrades. CHS saw the opposite pattern, a modest acuity decline in its surgical mix, but pointed to a year-over-year volume increase in June and expects "continued improvement there, particularly [in] the fourth quarter."

The strategic response across all four companies centers on outpatient capacity. Johnson called expansion of CHS's ambulatory footprint a "top priority," citing four ambulatory surgical center acquisitions or openings this year alone. Hazen said HCA will have acquired roughly a billion dollars of new facilities in 2026, mostly outpatient sites including ambulatory surgical centers and urgent care locations. He noted most recent acquisition opportunities have appeared in the outpatient space, and the company intends to keep investing there.

Tenet remains the most heavily weighted toward ambulatory capacity of the group, with USPI operating more than 550 locations. Sutaria was blunt about why that matters given the current regulatory climate. "In an industry where so much of the recent regulatory activity has not been overtly favorable to the broader sector, having half of our business where virtually everything that comes out from a regulatory perspective is a tailwind, or a benefit to the business, or will help grow and diversify the business over time, it's terrific, right?" he said. "I think that's very much helpful to us."

The Bottom Line

The consistent thread across four separate management teams is that nobody is waiting for elective surgery demand to snap back. Coverage losses tied to exchange disenrollment and a genuinely more price-conscious patient base appear to be structural rather than cyclical, at least in these companies' own planning assumptions. The capital is following that logic: outpatient and ambulatory investment is absorbing the bulk of new spending, betting that where care is delivered matters more right now than how much of it gets delivered. For hospital workforce planning, that shift points toward continued growth in ambulatory staffing needs even as inpatient surgical hiring stays flat or contracts, a divergence worth watching as 2026 guidance plays out.